PepGen Inc. Updates Principal Executive Office Address

TL;DR

**PepGen Inc. moved its main office, no big deal for investors.**

AI Summary

PepGen Inc. filed an 8-K on January 17, 2024, to update its principal executive offices from 1 Marina Park Drive, Suite 900, Boston, MA 02210 to 321 Harrison Avenue, 8th Floor, Boston, MA 02118. This change in address is a minor administrative update and does not reflect any operational or financial shifts, so it should not significantly impact investors' perception of the stock.

Why It Matters

This filing indicates a routine administrative change for PepGen Inc., specifically a new corporate address. It has no direct bearing on the company's financial health, operations, or strategic direction.

Risk Assessment

Risk Level: low — The filing only reports a change in the company's physical address, which is a minor administrative event with no inherent financial or operational risk.

Analyst Insight

Smart investors would recognize this as a purely administrative update with no material impact on PepGen Inc.'s valuation or future prospects, thus requiring no immediate action.

Key Players & Entities

• PepGen Inc. (company) — the registrant filing the 8-K
• 1 Marina Park Drive, Suite 900, Boston, MA 02210 (address) — PepGen Inc.'s former principal executive office address
• 321 Harrison Avenue, 8th Floor, Boston, MA 02118 (address) — PepGen Inc.'s new principal executive office address
• January 17, 2024 (date) — date of earliest event reported and filing date

FAQ

Key Financial Figures

• $0.0001 — ch registered Common stock, par value $0.0001 per share PEPG Nasdaq Global Select

Filing Documents

• pepg-20240117.htm (8-K) — 37KB
• pepg-ex99_1.htm (EX-99.1) — 10KB
• img148377401_0.jpg (GRAPHIC) — 5KB
• 0000950170-24-004824.txt ( ) — 171KB
• pepg-20240117.xsd (EX-101.SCH) — 25KB
• pepg-20240117_htm.xml (XML) — 5KB

01 Other Events

Item 8.01 Other Events. On January 17, 2024 PepGen Inc. (the “Company”) announced the appointment of Mary Beth DeLena as General Counsel and Secretary of the Company. A copy of the press release issued in connection with this announcement is being furnished as Exhibit 99.1 to this Current Report on Form 8-K.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits: Exhibit Number Description 99.1 Press release issued by PepGen inc. on January 17, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PEPGEN INC. Date: January 17, 2024 By: /s/ Noel Donnelly Noel Donnelly, Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR